Partagez sur FacebookPartagez sur TwitterEnvoyer par courriel

49- Translocator protein (TSPO) genotype does not change cerebrospinal fluid levels of glial activation, axonal and synaptic damage markers in early Alzheimer’s disease.

Neuroimage Clin. 2024 May 31;43:103626. doi: 10.1016/j.nicl.2024.103626.